Bridging Biomedical Worlds 2018 meeting

Genome Editing: The Next Frontier

As international collaborations in new and exciting research fields are forged between East and West, it seemed fitting for Fondation IPSEN and the American Association for the Advancement of Science to launch this new “Bridging Biomedical Worlds” conferences series. With these annual international conferences, to be held in different countries in Asia, we hope not only to facilitate the exchange of knowledge about important advances in key research areas but also to boost communication and cooperation among researchers, clinicians, and industry scientists from East and West. The discovery of CRISPR/Cas, a natural immune defense system in bacteria, has revolutionized genome editing enabling precise and highly efficient cutting and splicing of genomes from across the animal and plant kingdoms. The power and potential of CRISPR/Cas and other genome editing tools for both studying basic biological processes and for understanding and treating a broad swath of diseases is the theme of our 2018 Bridging Biomedical Worlds conference. This conference, entitled “Genome Editing: The Next Frontier”, has been held in Singapore, February 4-7, 2018, and is jointly organized by Foundation IPSEN, AAAS/Science and AAAS/Science Translational Medicine, and the Institute of Molecular and Cell Biology A*STAR Singapore. The meeting covered a broad range of topics including natural bacterial immune mechanisms, the next generation of genome editing tools, applications of genome editing tools in scientific discovery, and therapeutic applications of genome editing.

View full program